Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on APIs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110117254B reveals a streamlined 3-step route for Cabozantinib, replacing hazardous nitration with efficient one-pot reduction and copper-catalyzed decarboxylation for superior supply chain stability.
Patent CN111116593A details a continuous, low-cost Ibrutinib synthesis featuring raw material recycling and simplified purification for scalable pharmaceutical manufacturing.
Novel method improves purity and reduces thiol impurities. Enhances supply chain stability for pharmaceutical manufacturers seeking cost reduction.
Patent CN114195881B reveals a novel ionic liquid method for high-purity Sermorelin Acetate production, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN101560206A details a high-yield synthesis route for pemetrexed intermediates, offering significant cost reduction and scalable manufacturing for global supply chains.
Patent CN102584732B reveals a novel crystallization method for Plerixafor synthesis, offering superior purity and cost reduction in API manufacturing for global supply chains.
Novel green route for Abemaciclib intermediate using Selectfluor. Eliminates Palladium residues and reduces costs. Ideal for API manufacturing scale-up.
Novel synthesis of Levetiracetam avoiding toxic reagents. High purity API intermediate manufacturing with reduced environmental impact.
Novel alkali-modified mesoporous molecular sieve catalyst replaces NaOH for high-yield, scalable Pemetrexed Disodium production with superior purity.
Novel low-cost route for EGFR inhibitor intermediates via early acylation strategy ensuring high purity and supply stability for global pharmaceutical partners.
Patent CN101356158A details a robust Montelukast synthesis using stable thiolactone intermediates and activated cerium catalysis for superior purity and supply chain reliability.
Advanced refining method for Lenvatinib Mesylate achieving >99.8% purity. Optimized crystallization reduces costs and ensures supply chain reliability for pharmaceutical manufacturers.
Discover a novel bromfenac sodium synthesis method avoiding indole impurities. Enhanced purity, stable pH, and scalable production for pharmaceutical supply chains.
Patent CN104003936A details a high-purity refining method for Dextromethorphan Hydrobromide, ensuring significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN102887885A details a high-purity Esomeprazole Sodium synthesis via inclusion complex resolution, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN116354976A reveals a novel binary solvent purification method for camptothecin derivatives, achieving over 99% purity without column chromatography for reliable supply.
Patent CN1075718A reveals a novel metal alkoxide route for Taxol synthesis, offering high stereoselectivity and cost reduction in API manufacturing for global supply chains.
Novel synthesis of benzimidazole compound (I) via late-stage Suzuki coupling. Reduces cost and improves scalability for oncology intermediates.
Patent CN102351870A reveals a novel benzacridine synthesis route targeting c-myc DNA, offering scalable production and cost-effective API intermediate manufacturing solutions.
Patent CN109575109B reveals a novel fragment condensation method for Degarelix, offering significant cost reduction and high purity for reliable peptide API supply chains.